WHO ICTRP trial
Comparative study for the effects of venlafaxine and duloxetine in the treatment…
ChiCTR1900028259 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR1900028259 |
|---|---|
| Public title | Comparative study for the effects of venlafaxine and duloxetine in the treatment of chemotherapy-induced peripheral neuropathy |
| Scientific title | Comparative study for the effects of venlafaxine and duloxetine in the treatment of chemotherapy-induced peripheral neuropathy |
| Primary sponsor | The Second Affiliated Hospital of Fujian Medical University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Countries | China |
| Conditions | cancer |
| Interventions | blank control group:CIPN is treated with venlafaxine or duloxetine;experimental group:CIPN is treated with venlafaxine or duloxetine |
| Registration date | Dec 16, 2019 |
| Target size | blank control group:40;experimental group:80 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: